| Interventional pain treatments for cancer pain. | |
| | |
MedLine Citation:
|
PMID: 18837908 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cancer pain is prevalent and often multifactorial. For a segment of the cancer pain population, pain control remains inadequate despite full compliance with the WHO analgesic guidelines including use of co-analgesics. The failure to obtain acceptable pain or symptom relief prompted the inclusion of a fourth step to the WHO analgesic ladder, which includes advanced interventional approaches. Interventional pain-relieving therapies can be indispensable allies in the quest for pain reduction among cancer patients suffering from refractory pain. There are a variety of techniques used by interventional pain physicians, which may be grossly divided into modalities affecting the spinal canal (e.g., intrathecal or epidural space), called neuraxial techniques and those that target individual nerves or nerve bundles, termed neurolytic techniques. An array of intrathecal medications are infused into the cerebrospinal fluid in an attempt to relieve refractory cancer pain, reduce disabling adverse effects of systemic analgesics, and promote a higher quality of life. These intrathecal medications include opioids, local anesthetics, clonidine, and ziconotide. Intrathecal and epidural infusions can serve as useful methods of delivering analgesics quickly and safely. Spinal delivery of drugs for the treatment of chronic pain by means of an implantable drug delivery system (IDDS) began in the 1980s. Both intrathecal and epidural neurolysis can be effective in managing intractable cancer-related pain. There are several sites for neurolytic blockade of the sympathetic nervous system for the treatment of cancer pain. The more common sites include the celiac plexus, superior hypogastric plexus, and ganglion impar. Today, interventional pain-relieving approaches should be considered a critical component of a multifaceted therapeutic program of cancer pain relief. |
| | |
Authors:
|
Paul J Christo; Danesh Mazloomdoost |
Related Documents
:
|
8799348 - Effective pain management in terminal care. 8912378 - Cancer therapy using bone-seeking isotopes. 15972088 - Disparities between black and white patients with cancer pain: the effect of perception... 17445618 - Bilateral high-level percutaneous cervical cordotomy in cancer pain due to lung cancer:... 22711398 - A case of a giant submandibular gland calculus perforating the floor of the mouth. 7994728 - The diagnosis and treatment of discoid lupus erythematosus with oral manifestations onl... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Annals of the New York Academy of Sciences Volume: 1138 ISSN: 1749-6632 ISO Abbreviation: Ann. N. Y. Acad. Sci. Publication Date: 2008 Sep |
Date Detail:
|
Created Date: 2008-10-07 Completed Date: 2008-10-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7506858 Medline TA: Ann N Y Acad Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 299-328 Citation Subset: IM |
Affiliation:
|
Department of Anesthesiology & Critical Care Medicine, Division of Pain Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. pchristo@jhmi.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics
/
administration & dosage,
therapeutic use* Humans Neoplasms / complications* Pain / drug therapy*, etiology |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cancer pain and analgesia.
Next Document: Febrile neutropenia.